Here is a complete, textbook-backed explanation:
Why Phenytoin is Problematic for IV Use
1. Poor Water Solubility - The Root Problem
Phenytoin free base has very poor water solubility (pKa 8.06-8.33). To make it injectable, the formulation contains propylene glycol and ethanol, adjusted to pH 12. These excipients are the main source of IV toxicity, not the phenytoin molecule itself.
- Katzung's Basic and Clinical Pharmacology, 16th Ed
2. Cardiovascular Toxicity (the main reason it is avoided as IV push)
Rapid IV administration causes serious cardiovascular complications, almost entirely due to the propylene glycol and ethanol vehicle:
| Complication | Details |
|---|
| Hypotension | Decreased peripheral vascular resistance; seen in ~8% of cases |
| Bradycardia | Slowed conduction through the AV node |
| Conduction delays | Prolonged PR interval, widened QRS |
| AV block | Can progress to complete AV block |
| Ventricular tachycardia / fibrillation | In severe cases |
| Asystole | Life-threatening |
Cardiovascular toxicity is more common in the elderly, those with underlying cardiac disease, and the critically ill.
- Tintinalli's Emergency Medicine, p. 1326
These effects are not seen with chronic oral phenytoin or acute oral overdose - they are uniquely tied to the IV formulation vehicle.
3. Local Tissue Toxicity - "Purple Glove Syndrome"
IV phenytoin causes a unique and serious local complication:
-
Purple glove syndrome: purplish-black discoloration, edema, and pain distal to the injection site
-
Can progress to tissue necrosis, compartment syndrome, and even limb gangrene if extravasation occurs
-
The highly alkaline pH (12) and propylene glycol are both irritants to vessel walls
-
Washington Manual of Medical Therapeutics
4. Incompatibility with Dextrose Solutions
Phenytoin precipitates immediately in dextrose (5% D5W) - it can only be given in normal saline. This further restricts its practical IV use.
5. Rate Restriction (If IV Is Used)
If phenytoin must be given IV, the maximum rate is 50 mg/min (25 mg/min in the elderly or those with cardiac disease), with continuous cardiac monitoring. Even at these rates, hypotension and bradycardia can occur.
6. The Solution: Fosphenytoin
Because of all the above, fosphenytoin (a water-soluble prodrug) was developed:
-
No propylene glycol - uses standard aqueous vehicles
-
Can be given 3x faster than IV phenytoin (up to 150 mg phenytoin equivalents/min)
-
Compatible with both saline and dextrose
-
Lower incidence of purple glove syndrome
-
Rapidly converted to phenytoin in plasma by phosphatases (half-life ~8-15 min)
-
Also usable intramuscularly
-
Goodman & Gilman's Pharmacological Basis of Therapeutics
Summary Table
| Problem | Cause |
|---|
| Hypotension / bradycardia / arrhythmias | Propylene glycol + ethanol vehicle |
| Purple glove syndrome / tissue necrosis | Alkaline pH (12) + propylene glycol |
| Precipitates in IV lines | Incompatible with dextrose, other drugs |
| Unpredictable IM absorption | Drug precipitates in muscle |
| Solution | Use fosphenytoin instead |